Your browser doesn't support javascript.
loading
Deep brain stimulation for obsessive-compulsive disorder: Knowledge and concerns among psychiatrists, psychotherapists and patients.
Naesström, Matilda; Blomstedt, Patric; Hariz, Marwan; Bodlund, Owe.
Afiliação
  • Naesström M; Department of Clinical Sciences/Psychiatry, Umeå University, Sweden.
  • Blomstedt P; Unit of Deep Brain Stimulation, Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.
  • Hariz M; Unit of Deep Brain Stimulation, Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.
  • Bodlund O; Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square, London, United Kingdom.
Surg Neurol Int ; 8: 298, 2017.
Article em En | MEDLINE | ID: mdl-29285414
ABSTRACT

BACKGROUND:

Deep brain stimulation (DBS) is under investigation for severe obsessive-compulsive disorder (OCD) resistant to other therapies. The number of implants worldwide is slowly increasing. Therefore, it is of importance to explore knowledge and concerns of this novel treatment among patients and their psychiatric healthcare contacts. This information is relevant for scientific professionals working with clinical studies for DBS for this indication. Especially, for future study designs and the creation of information targeting healthcare professionals and patients. The aim of this study was to explore the knowledge and concerns toward DBS among patients with OCD, psychiatrists, and cognitive behavioral therapists.

METHODS:

The study was conducted through web-based surveys for the aimed target groups -psychiatrist, patients, and cognitive behavioral therapists. The surveys contained questions regarding previous knowledge of DBS, source of knowledge, attitudes, and concerns towards the therapy.

RESULTS:

The main source of information was from scientific sources among psychiatrists and psychotherapists. The patient's main source of information was the media. Common concerns among the groups included complications from surgery, anesthesia, stimulation side effects, and the novelty of the treatment. Specific concerns for the groups included; personality changes mentioned by patients and psychotherapists, and ethical concerns among psychiatrists.

CONCLUSION:

There are challenges for DBS in OCD as identified by the participants of this study; source and quality of information, efficacy, potential adverse effects, and eligibility. In all of which the current evidence base still is limited. A broad research agenda is needed for studies going forward.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Surg Neurol Int Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Surg Neurol Int Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia